Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value

Anthony V. Serritella, Garth W. Strohbehn, Daniel A. Goldstein, Allen S. Lichter, Mark J. Ratain*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Cancer care’s sustainability is challenged by drug expenditures. In the absence of systemic change, innovation is needed to curtail drug costs. Interventional pharmacoeconomics (IVPE) utilizes clinical research to identify safe, efficacious, cost-conscious dosing regimens to extract maximum value from expensive therapies. Strategies include de-escalation of dosage, treatment duration and administration frequency, and substitution with therapeutic alternatives. In this review, we discuss how IVPE strategies have been successfully used and could be implemented going forward.

Original languageEnglish (US)
Pages (from-to)487-493
Number of pages7
JournalClinical pharmacology and therapeutics
Volume108
Issue number3
DOIs
StatePublished - Sep 1 2020
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value'. Together they form a unique fingerprint.

Cite this